Read + Share
Amedeo Smart
Independent Medical Education
van Dalem J, Driessen JHM, Burden AM, Stehouwer CDA, et al. Thiazolidinediones and Glucagon-Like Peptide-1 Receptor Agonists and the Risk of Nonalcoholic Fatty Liver Disease: A Cohort Study. Hepatology 2021;74:2467-2477.PMID: 34129693
Email
LinkedIn
Facebook
Twitter
Privacy Policy